***Background.*** Treatment of cUTI due to Pseudomonas is challenging because of the organism\'s propensity to form biofilms and its intrinsic and acquired resistance to many antibiotics. Our objective was to identify risk factors for Pseudomonas as the causative pathogen among hospitalized patients with cUTI.

***Methods.*** We conducted a retrospective cohort study of cUTI among adult inpatients at an academic medical center from May 1, 2009 -- December 31, 2013. Pregnant patients or those without microbiology data were excluded. cUTI was defined as catheter-associated UTI (CAUTI); acute pyelonephritis; UTI in patients with uropathy or other urinary tract functional abnormality (UT abnormality), urogenital/anorectal surgery, urinary calculi, quadriplegia/paraplegia, spinal cord injury/disorder, kidney transplant, or end-stage renal disease; or UTI in males. Chi-square and Fisher\'s exact tests were used for bivariable analysis; forward stepwise multivariable logistic regression with p \< 0.25 entry and p \< 0.05 stay criteria was used to identify independent predictors of pseudomonal cUTI.

***Results.*** Among 2,598 patients included in the cohort, 202 (7.8%) had Pseudomonal cUTI. Bivariable analysis showed that patients with history of 1^st^/2^nd^ generation cephalosporin use, multiple sclerosis (MS), quadriplegia/paraplegia, UT abnormality, or male sex (all p \< 0.01) were more likely to have Pseudomonal cUTI. In the multivariable regression model, male sex (OR: 2.2, 95%CI: 1.6-3.0), CAUTI (OR: 1.5, 95% CI: 1.1-2.1), 1^st^/2^nd^generation cephalosporin use (OR: 1.8, 95% CI: 1.3-2.5), MS (OR: 2.6, 95% CI: 1.4-4.9), quadriplegia/paraplegia (OR: 3.0, 95% CI: 1.9-4.7), spina bifida (OR: 0.2, 95% CI: 0.1-0.7), and UT abnormality (OR: 1.9, 95% CI: 1.3-2.7) were identified as independent predictors of Pseudomonal cUTI.

***Conclusion.*** Patients with CAUTI or certain comorbidities associated with voiding problems or increased catheterization may be more likely to develop pseudomonal cUTI, however, those with spina bifida may be at reduced risk. While further work is needed to verify these risk factors and their mechanism for conferring risk, valid predictors may be useful to identify which cUTI patients should receive empiric anti-Pseudomonal agents.
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